CD

Carl Brendan Doyle

Harvard University: 3 patents #733 of 3,600Top 25%
US Ucb Biopharma Srl: 3 patents #103 of 349Top 30%
Overall (All Time): #904,283 of 4,157,543Top 25%
5
Patents All Time

Issued Patents All Time

Showing 1–5 of 5 patents

Patent #TitleCo-InventorsDate
12247068 Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Karen Inouye +6 more 2025-03-11
11518803 Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis Helene Bon, Joanne Elizabeth Compson, Kate Louise Dixon, Mark Ellis, Maria Margarida Gouveia Sancho +9 more 2022-12-06
11014979 Anti-AP2 antibodies and antigen binding agents to treat metabolic disorders Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Elisabeth Helen Roberts +6 more 2021-05-25
10766956 Antagonist antibodies that bind to human TGFB1, TGFB2 and to TGFB3 and their use for the treatment of lung fibrosis Helene Bon, Joanne Elizabeth Compson, Kate Louise Dixon, Mark Ellis, Maria Margarida Gouveia Sancho +9 more 2020-09-08
10160798 Anti-aP2 antibodies and antigen binding agents to treat metabolic disorders Gokhan S. Hotamisligil, Mehmet F. Burak, Feyza Engin, Scott B. Widenmaier, Elisabeth Helen Roberts +5 more 2018-12-25